- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01577927
Feasibility Study of a Home Rehabilitative Network to Treat Prolonged Weaned Patients (UTIR)
Feasibility and Efficacy of a Home Rehabilitative Network for Prolonged Weaned Patients Discharged From a Weaning Unit
Patients at high complexity with severe chronic diseases can require several admission in intensive care units (ICU) to overcome acute exacerbations by the use of assisted ventilation. In the last 10 years, new technologies and beds in ICU evidenced a new group of patients often needing weaning procedures due to a long-lasting period of mechanical ventilation. These patients are often under chronic conditions with recurrent symptoms, reduced effort tolerance and depression.
Weaning process is a frail step in the medical history of a patient who has survived an acute episode of respiratory failure and has spent a period of time under mechanical ventilation. Patients are followed for the duration of in-hospital stay, an expected average period of 4 weeks.
When discharged fron an Intensive Care Unit (ICU) or a weaning center, the patient is usually managed by GPs and by the hospital where he has been admitted to following re-exacerbations. The conventional approach is for sure inadequate for this type of patient whose clinical complexity, disability and frailty need for a continuity of care through a higher complex approach of management.
A structured program of Home Rehabilitation could be a possible solution to this problem. Thus, the hypothesis of the study is to evaluate feasibility and sustainability and efficacy of a home rehabilitative network for prolonged weaned patients discharged from a weaning unit.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Brescia
-
Lumezzane, Brescia, Italy, 25065
- Fondazione Salvatore Maugeri
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
- General Inclusion criteria: 1. Signature of the informed 2. Good expectation of life
- Specific Inclusion Criteria : Score of general dependences < 19 according to the Critical Patients Autonomy Planning (CPAP) Scale
Exclusion Criteria:
- Patient with neuromuscular, highly progressive neurological diseases (i.e. amyotrophic lateral sclerosis), patient requiring surgical interventions, sedation, and hemodialysis.
- Unstable patient conditions as daily variability of the blood arterial pressure >20%, arrhythmias, PaO2/FiO2 < 300, unsatisfactory respiratory pattern, haemoglobin < 7 g /dL, temperature > 38°C, presence of neurological or orthopaedic side effects, and recent embolisms from TVP. Refusal.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual home care
No assistance or care by PT.
|
Usual home care consists in supporting drug and oxygen therapy, mechanical ventilation, GP's assistance,and periodical in-hospital visit.
|
|
Experimental: PT-assisted home rehabilitation
Assisted home care is supported by a PT at least 2 times/month.
Few brief educational lessons preceeded the training activity that the patient performs by himself at home.
|
Patient performs 50 min physical activity/working day autonomously by the help of a DVD. The physical activity consists in cyclette, calisthenic exercises, and training of the respiratory muscles. Every two weeks, PT phones the patient for an educational reinforcement. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Critical Patients Autonomy Planning (CPAP)
Time Frame: Changes from baseline and 4 weeks, and 6 months after home activity
|
CPAP is a measure of dependency.
CPAP was evaluated at three different time-points: at in-hospital admission (baseline), at discharge (patients are followed for the duration of their in-hospital stay, an expected average time of 4 weeks), and after 6 months of physical activity at home.
|
Changes from baseline and 4 weeks, and 6 months after home activity
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)
Time Frame: Changes from baseline and 4 weeks (average time), and 6 months after home activity
|
Respiratory Functionality
|
Changes from baseline and 4 weeks (average time), and 6 months after home activity
|
|
MRF 26
Time Frame: Changes between discharge at 4 weeks (average time) and 6 months after home activity
|
Quality of life evaluation.
|
Changes between discharge at 4 weeks (average time) and 6 months after home activity
|
|
Likert Scale
Time Frame: Changes between discharge at 4 weeks (average time) and 6 months after home activity
|
Satisfaction for patient/caregiver
|
Changes between discharge at 4 weeks (average time) and 6 months after home activity
|
|
Mortality
Time Frame: Changes between 3, 6 and 12 months post-discharge
|
Clinical measure
|
Changes between 3, 6 and 12 months post-discharge
|
|
MRC Scale and/or dynamometer
Time Frame: Changes between baseline, discharge at 4 weeks, and 6 months after home activity
|
Rehabilitative measure referring to muscles force
|
Changes between baseline, discharge at 4 weeks, and 6 months after home activity
|
|
6-min walking test
Time Frame: Changes from baseline and discharge at 4 weeks, and 6 months after home activity
|
Rehabilitative measure evaluating the effort tolerance.
|
Changes from baseline and discharge at 4 weeks, and 6 months after home activity
|
|
EuroQol
Time Frame: Changes between discharge at 4 weeks (average time) and 6 months after home activity
|
Quality of life evaluation
|
Changes between discharge at 4 weeks (average time) and 6 months after home activity
|
|
Gussago Nursing Scale
Time Frame: Changes from baseline and 4 weeks, and 6 months after home activity
|
Measure of dependency.
|
Changes from baseline and 4 weeks, and 6 months after home activity
|
|
Barthel Index
Time Frame: Changes from baseline and 4 weeks, and 6 months after home activity
|
Measure of dependency.
|
Changes from baseline and 4 weeks, and 6 months after home activity
|
|
Pre-morbidity life-style (PLS)
Time Frame: Changes from baseline and 4 weeks, and 6 months after home activity
|
Measure of dependency.
|
Changes from baseline and 4 weeks, and 6 months after home activity
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Piero Ceriana, MD, Fondazione Salvatore Maugeri
- Study Director: Michele Vitacca, MD, Fondazione Salvatore Maugeri
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UTIR
- Dlg. 5685 on 28 May 2010 (Other Grant/Funding Number: Lombardy Region)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Diseases
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Radboud University Medical CenterCompleted
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Children's Hospital Los AngelesOrganonCompletedChronic Conditions, MultipleUnited States
-
National Cancer Institute (NCI)CompletedChildhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
University of LimerickCompletedChronic Conditions, MultipleIreland
Clinical Trials on Usual home care
-
The University of Texas Health Science Center,...Centers for Medicare and Medicaid Services; Texas Department of State Health...Completed
-
University of Southern CaliforniaPatient-Centered Outcomes Research InstituteTerminatedCancer | Chronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States
-
Columbia UniversityUnited States Department of DefenseCompleted
-
Icahn School of Medicine at Mount SinaiNYU Langone Health; National Institutes of Health (NIH); National Institute on... and other collaboratorsTerminated
-
Massachusetts General HospitalMedically HomeActive, not recruitingLymphoma | Head and Neck Cancer | Pancreatic Cancer | Rectal Cancer | GastroEsophageal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Head and Neck Cancer | Gynecologic Cancer | Ovarian Cancer | Thoracic Cancer | Head and Neck Tumor | Gynecologic Tumor | Thoracic TumorUnited States
-
The University of Hong KongCompletedFrailty | GeriatricsHong Kong
-
Fondazione Salvatore MaugeriCompleted
-
Universidade Cidade de Sao PauloUnknown
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinRecruitingSymptomatic Lumbar Spinal StenosisFrance